PDF
ePub
Citation
Print
초록
Purpose
The purpose of this study was to identify the effects of erectile capacity, lower urinary tract symptoms, self-esteem, and resilience on the quality of life of prostate cancer patients.
Methods
Data were collected using a self–reported questionnaire survey. Participants were 140 patients diagnosed and treated for prostate cancer in hospitals in Busan and Daegu cities. Measured variables were erectile capacity, lower urinary tract symptoms, self-esteem, resilience and quality of life. Result: Erectile capacity, lower urinary tract symptoms, self-esteem, and resilience all had significant effects on quality of life. Explained variance for quality of life was 40.6% and lower urinary tract symptoms was the most significant factor affecting the quality of life of prostate cancer patients.
REFERENCES
1. Kim DS, Byun SS, Lee SE, Lee E, Choi HY, Chung BH, et al. The features and prognosis of Korean who underwent radical prostatectomy in prostate cancer. Korean J Urol. 2010; 8:40–6.
2. National Cancer Information Center (KR). Survival rates [Internet]. Available from. https://www.cancer.go.kr/lay1/S1T648C650/contents.do. [Assessed June 4, 2017].
3. The Korean Prostate Society. Prostate cancer [Internet]. Available from. http://www.theprostate.org/infor/sub4.php. [Assessed June 4, 2017].
4. McCaughan E, Prue G, McSorley O, Northouse L, Schafenacker A, Parahoo K. A randomized controlled trial of a self-management psychosocial intervention for men with prostate cancer and their partners: a study protocol. J Adv Nurs. 2013; 69:2572–83.
5. Hugosson J, Stranne J, Carlsson SV. Radical retropubic prostatectomy: a review of outcomes and side-effects. Acta Oncol. 2011; 50(Suppl 1):92–7.
6. Gotay CC, Kawamoto CT, Bottomley A, Efficace F. The prognostic sig-nificance of patient-reported outcomes in cancer clinical trials. J Clin Oncol. 2008; 26:1355–63.
7. Byun HS, Kim GD, Chung BY, Kim KH. Fatigue and quality of life of Korean cancer inpatients. Korean J Hosp Palliat Care. 2010; 13:98–108.
8. Choe JH, Choi YS, Choi HJ, Choi HY, Lee SW. Quality of life and sexual outcomes: radical prostatectomy and external beam radiation therapy for prostate cancer. Korean J Urol. 2005; 46:962–9.
9. Youn GH. A cultural perspective of erectile capacity and ejaculation. Korean J Androl. 2008; 26:178–86.
10. Engström G, Henningsohn L, Walker-Engström ML, Leppert J. Impact on quality of life of different lower urinary tract symptoms in men measured by means of the SF 36 questionnaire. Scand J Urol Nephrol. 2006; 40:485–94.
11. Rogenberg M. Society and adolecent self-image. Princenton, NJ: Princenton University Press. 1965.
12. Joung KS, Lee MS, Gu JH, Oh KO. Effect of horticultural activity on self-esteem and quality of life in cancer patients. 2011 Society for People, Plants, and Environment Fall Conference; 2011 Nov 4; Seoul, Korea. Wanju: Society for People, Plants, and Environment. 2011. 67–8.
13. Monahan PO, Champion V, Rawl S, Giesler RB, Given B, Given CW, et al. What contributes more strongly to predicting QOL during 1-year recovery from treatment for clinically localized prostate cancer: 4-weeks-post-treatment depressive symptoms or type of treatment? Qual Life Res. 2007; 16:399–411.
14. Connor KM, Davidson JR. Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC). Depress Anxiety. 2003; 18:76–82.
15. Kim JI, Byeon YS. A study on the factors affecting resilience in patients with colon cancer. Asian Oncol Nurs. 2013; 13:256–64.
16. Lee JH. Sexual life, sexual satisfaction and quality of Life in elderly patients with prostate cancer [dissertation]. Seoul: Korea Univ.;2015.
17. Park JE, Lee HJ, Lee SH. Factors related to the quality of life of prostate cancer patients scheduled for prostatectomy within 2 weeks. Glob Health Nurs. 2015; 5:38–44.
18. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999; 11:319–26.
19. Ahn TY, Lee DS, Kang WC, Hong JH, Kim YS. Validation of an abridged Korean version of the international index of erectile function (IIEF-5) as a diagnostic tool for erectile dysfunction. Korean J Urol. 2001; 42:535–40.
20. Kim JS, Moon VN. Factors influencing health-related quality of life in patients with benign prostatic hyperplasia. J Korean Acad Nurs. 2010; 40:287–97.
21. Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urological Association Symptom Index for benign prostatic hyperplasia. J Urol. 1992; 148:1549–57.
22. Choi HR, Chung WS, Shim BS, Kwon SW, Hong SJ, Chung BH, et al. Translation validity and reliability of I-PSS Korean version. Korean J Urol. 1996; 37:659–65.
23. Jeon BJ. Self-esteem: a test of its measurabilty. Yonsei Nonchong. 1974; 11:107–30.
24. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993; 11:570–9.
25. Cho IC, Kim SB, Kim YS, Choi JY, Min SK. Analysis of correlation between the national institutes of health chronic prostatitis symptom index (NIH-CPSI) and international index of erectile function (IIEF-5) among Korean males aged 40–50s. Korean J Urogenit Tract Infect In-flamm. 2012; 7:164–71.
26. Park MK. Life style & erectile dysfunction. Korean Soc Sex Med An-drol. 2016; 14:22–6.
27. Li HC, Chen KM, Lin YH, Chen TB. Lower urinary tract symptoms of prostate cancer patients undergoing treatments over eight-month Follow-up. J Clin Nurs. 2015; 24:2239–46.
28. Yang J, Yi M. Factors influencing quality of life in thyroid cancer patients with thyroidectomy. Asian Oncol Nurs. 2015; 15:59–66.
29. Kim HW, Choi-Kwon S. Structural equation modeling on quality of life in pre-dialysis patients with chronic kidney disease. J Korean Acad Nurs. 2012; 42:699–708.
30. Seo YM. Lower urinary tract symptoms, self-management and quality of life in middle aged men. J Korean Acad Community Health Nurs. 2010; 21:303–10.
Table 1.
QOL of General Characteristics (N =140)
| Variables | Characteristics | Categories | n (%) | M ± SD | t or F (p) | Scheffé |
|---|---|---|---|---|---|---|
| Sociodemographic characteristics | Age (Year) | ＜65 a | 20(14.3) | 70.90 ± 15.99 | 3.58 | a＞ b, c |
| 65~＜75 b | 79(56.4) | 63.31 ± 10.85 | (.031) | |||
| ≥75 c | 41(29.3) | 62.50 ± 12.88 | ||||
| Religion | Yes | 67(47.9) | 64.59 ± 12.80 | 0.40 | ||
| No | 73(52.1) | 63.75 ± 12.31 | (.692) | |||
| Education | ≤ Middle School a | 44(31.4) | 59.03 ± 12.12 | 7.63 | c＞ a | |
| High School b | 63(45.0) | 63.57 ± 12.00 | (.001) | |||
| ≥ College c | 33(23.6) | 69.30 ± 12.40 | ||||
| Monthly income (10,000 won/month) | ≤100 a | 51(36.4) | 62.82 ± 13.44 | 4.50 | d＞ a, b, c | |
| 101~200 b | 45(32.1) | 62.80 ± 10.19 | (.005) | |||
| 201~300 c | 40(28.6) | 65.30 ± 12.54 | ||||
| ≥301 d | 4(2.9) | 85.00 ± 4.00 | ||||
| Occupation (premorbid) | Yes | 106(75.7) | 65.23 ± 12.36 | 1.80 | ||
| No | 34(24.3) | 60.82 ± 12.56 | (.074) | |||
| Occupation (postmorbid) | Yes | 49(35.0) | 67.41 ± 13.47 | 2.19 | ||
| No | 91(65.0) | 62.41 ± 11.67 | (.031) | |||
| Family (person) | 1~3 | 83(59.3) | 63.00 ± 12.48 | -1.32 | ||
| ≥4 | 57(40.7) | 65.84 ± 12.46 | (.188) | |||
| Disease relating characteristics | Illness duration (year) | ＜1 a | 36(25.7) | 68.36 ± 11.69 | 4.48 | a＞ c |
| 1~＜3 b | 43(30.7) | 65.26 ± 10.62 | (.013) | |||
| ≥3 c | 61(43.6) | 60.90 ± 13.48 | ||||
| Cancer Stage of diagnosis (year) | 1 | 54(38.6) | 61.50 ± 12.62 | 2.02 | ||
| 2 | 36(25.7) | 66.00 ± 13.53 | (.137) | |||
| 3 | 50(35.7) | 65.70 ± 11.32 | ||||
| Recurrence | Yes | 10(7.1) | 68.20 ± 9.44 | 1.06 | ||
| No | 130(92.9) | 63.85 ± 12.69 | (.291) | |||
| Treatment modality | Chemotherapy | 17(12.1) | 64.53 ± 13.31 | 1.78 | ||
| Radiotherapy | 26(18.6) | 69.00 ± 15.00 | (.121) | |||
| Operation | 59(42.1) | 62.58 ± 11.98 | ||||
| Hormone therapy | 17(12.1) | 58.94 ± 9.88 | ||||
| Operation+Others | 13(9.3) | 65.85 ± 11.09 | ||||
| Others∗ | 8(5.7) | 67.62 ± 9.01 | ||||
| Underlying disease | Yes† | 64(45.7) | 64.55 ± 12.91 | 0.41 | ||
| No | 76(54.3) | (.685) | ||||
| Ambulation | Moderate a | 130(92.9) | 63.69 ± 12.10 | 6.02 | a, b＞ c | |
| Less than 50 % lying b | 6(4.3) | 64.75 ± 12.28 | (.003) | |||
| More than 50 % lying | 4(2.9) | 65.17 ± 4.22 | ||||
| down c | ||||||
| Perceived health status | 0~4 a | 19(13.6) | 43.50 ± 12.12 | 9.51 | c＞ a, b | |
| 5~7 b | 85(60.7) | 58.32 ± 10.21 | (＜.001) | |||
| 8~10 c | 36(25.7) | 62.49 ± 11.35 |
Table 2.
Means and Standard Deviation of QOL, Erectile Capacity, LUTS, Self - esteem, Resilience (N =140)
Table 3.
Correlation among Erectile Capacity, LUTS, self-es-teem, Rsilience and QOL (N =140)
| Variables | QOL | |
|---|---|---|
| r | p | |
| Erectile capacity | .37 | ＜.001 |
| LUTS | -.53 | ＜.001 |
| Self-esteem | .37 | ＜.001 |
| Resilience | .04 | .625 |
Table 4.
Multiple Regression Analys sis on QOL (N =140)
QOL= Quality of life; LUTS= Lower urinary tract symptoms; Dummy variable: *Cancer Stage of diagnosis (Year) (1:＜3, 0:≥3), † Perceived health status (1:≥8, 0:≤7), ‡ Ambulation (1: Moderate or Less than 50 % lying, 0: More than 50 % lying down), § Occupation (postmorbid) (1: Yes, 0: No), || Monthly income (10,000 won) (1:≥301, 0:≤300), ¶ Education (1:≥ College, 0:≤ High School), # Age (year) (1:＜65, 0:≥65).
XML Download